Integra Lifesciences Introduces Joint Fusion System

Integra Lifesciences Holdings Corp. has released its IPP-ON PIP Fusion System, for fixation of proximal interphalangeal (PIP) joint arthrodesis. Arthrodesis, also known as artificial ankylosis or syndesis, is the artificial induction of joint ossification, or laying down new bone material, between two bones via surgery. The system is indicated for use in the lesser toes for rigid or semi-rigid hammertoe deformity, revision of failed arthroplasty or arthrodesis, and second toe shortening. The U.S. Food and Drug Administration has granted the device 510(k) clearance.

Hammertoe is a deformity that occurs when there is a shortening of the tendon that controls toe movement. The shortened tendon causes the middle joint of the toe to be bent upward and the most distal joint downward.

“Integra IPP-ON PIP Fusion System offers surgeons a straightforward, one-piece alternative to hammertoe fixation,” said Bill Weber, vice president and general manager of Integra Extremity Reconstruction. “Unlike some similar products, our device is not temperature sensitive and has no handling or storage requirements. This is an excellent feature, since it is ready for use whenever the surgeon needs it. This system is a valuable addition to our already extensive portfolio of forefoot extremity products.”

The system is constructed as one stainless steel piece. a one-piece, stainless steel interphalangeal fusion device that is available in two sizes, to accommodate varying patient anatomy. The device is touted as anatomically adaptive by offering both cortical bone (or compact bone) and cancellous bone fixation.

The Integra IPP-ON PIP Fusion System is distributed through Integra’s Extremity Reconstruction sales organization, which focuses on lower extremity fixation, upper extremity fixation, tendon protection, peripheral nerve repair/protection and wound repair. The company is headquartered in Plainsboro, N.J.